Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human KCNN4 ELISA Kit (AC3228)
Cat.#: ASET-1817
Specifications
Description Human KCNN4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNN4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 12.09 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1382 Monkey Apolipoprotein E ELISA Kit (AC2793) Quantitative inquiry ASET-2148 Human Myocilin ELISA Kit (AC3559) Quantitative inquiry ASET-2217 Human CCR5 ELISA Kit (AC3628) Quantitative inquiry ASET-1163 Human Ephrin B1 ELISA Kit (AC2574) Quantitative inquiry ASET-2287 Human HMT ELISA Kit (AC3698) Quantitative inquiry ASET-1192 Human DISC1 ELISA Kit (AC2603) Quantitative inquiry ASET-1521 Porcine eNOS ELISA Kit (AC2932) Quantitative inquiry ASET-2133 Bovine S100A8 ELISA Kit (AC3544) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket